In addition, the transplanted cells may also attack, or keep at bay, any remaining myeloma cells in the transplant recipient's body, a process known as the "graft-versus-myeloma" effect.
Myeloma cells produce monoclonal proteins of varying types, most commonly immunoglobulins (antibodies) and free light chains, resulting in abnormally high levels of these proteins in the blood.